RNLX(Delisted)
RenalytixยทNASDAQ
--
--(--)
RNLX Profile
Renalytix Plc
A UK-based company that develops artificial intelligence-enabled vitro diagnostic solutions for kidney diseases
--
03/15/2018
07/17/2020
NASDAQ Stock Exchange
110
06-30
Depository Receipts (Ordinary Shares)
2 Leman Street, London, United Kingdom E1W 9US
--
Renalytix plc was incorporated on 15 March 2018 as a public limited company under the laws of England and Wales. The company is an in vitro diagnostic company with artificial intelligence capabilities that optimizes the clinical management of kidney disease to improve patient prognosis and reduce medical costs.
